Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Nixon

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|March 15, 1976
Neurotoxicity of a non-metabolizable amino acid, 1 -aminocyclopentane-1-carboxylic acid (ACPC): ACPC transport mechanisms in tissuesR A Nixon
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1986
Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neuronsR A Nixon
American Journal of Mental Deficiency|September 1, 1970
Impact of automation and technological change on employabilty of the mentallyretardedR A Nixon
Brain Pathology (Zurich, Switzerland)|January 1, 1993
The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiologyR A Nixon
Annals of Neurology|October 1, 1978
Quinine sulfate for pain in the Guillain-Barré syndromeR A Nixon
Annals of the New York Academy of Sciences|February 24, 2001
A "protease activation cascade" in the pathogenesis of Alzheimer's diseaseR A Nixon
Neurobiology of Aging|January 1, 1994
Neuronal degenerative mechanisms as clues to pathogenesis and treatment of Alzheimer's diseaseR A Nixon
Brain Research|October 27, 1980
Protein degradation in the mouse visual system. I. Degradation of axonally transported and retinal proteinsR A Nixon
Annals of the New York Academy of Sciences|January 1, 1989
Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesisR A Nixon
Current Opinion in Cell Biology|March 4, 1998
The slow axonal transport of cytoskeletal proteinsR A Nixon
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|March 15, 1976
Neurotoxicity of a non-metabolizable amino acid, 1 -aminocyclopentane-1-carboxylic acid (ACPC): ACPC transport mechanisms in tissuesR A Nixon
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1986
Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neuronsR A Nixon
American Journal of Mental Deficiency|September 1, 1970
Impact of automation and technological change on employabilty of the mentallyretardedR A Nixon
Brain Pathology (Zurich, Switzerland)|January 1, 1993
The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiologyR A Nixon
Annals of Neurology|October 1, 1978
Quinine sulfate for pain in the Guillain-Barré syndromeR A Nixon
Annals of the New York Academy of Sciences|February 24, 2001
A "protease activation cascade" in the pathogenesis of Alzheimer's diseaseR A Nixon
Neurobiology of Aging|January 1, 1994
Neuronal degenerative mechanisms as clues to pathogenesis and treatment of Alzheimer's diseaseR A Nixon
Brain Research|October 27, 1980
Protein degradation in the mouse visual system. I. Degradation of axonally transported and retinal proteinsR A Nixon
Annals of the New York Academy of Sciences|January 1, 1989
Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesisR A Nixon
Current Opinion in Cell Biology|March 4, 1998
The slow axonal transport of cytoskeletal proteinsR A Nixon
Pageof 13